Healthcare Sector Review: Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Insmed Incorporated (NASDAQ:INSMD): The shares closed at $5.16, up $0.68, or 15.18%, on the day. Its market capitalization is $128.11 million. About the company: Insmed Incorporated is a development stage biopharmaceutical company with expertise in proprietary, advanced liposomal technology designed specifically for inhalation lung delivery.
  • Dynavax Tech. Corp. (NASDAQ:DVAX): The shares closed at $2.43, up $0.3, or 14.08%, on the day. Its market capitalization is $299.91 million. About the company: Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
  • Columbia Laboratories Inc (NASDAQ:CBRX): The shares closed at $2.46, up $0.23, or 10.31%, on the day. Its market capitalization is $214.68 million. About the company: Columbia Laboratories, Inc. is an international pharmaceutical company that develops and markets women’s health care and endocrinology products. The Company develops products intended to treat infertility, dysmenorrhea, endometriosis, and hormonal deficiencies, primarily utilizing its Bioadhesive Delivery System technology. Columbia markets Striant, and Prochieve 8% and 4%.
  • BioMimetic Therapeutics (NASDAQ:BMTI): The shares closed at $4.04, up $0.29, or 7.73%, on the day. Its market capitalization is $113.28 million. About the company: BioMimetic Therapeutics, Inc. develops and markets drug-device products for the repair of orthopedic injuries to bond, cartilage, ligaments, and tendons. The Company combines protein therapeutics with tissue scaffolds to stimulate tissue healing and regeneration.
  • Warner Chilcott Plc (NASDAQ:WCRX): The shares closed at $16.15, up $1.08, or 7.17%, on the day. Its market capitalization is $4.10 billion. About the company: Warner Chilcott PLC is a pharmaceutical company. The Company is focused on marketing, selling, developing and manufacturing branded prescription pharmaceutical products in women’s healthcare and dermatology in the United States.

Losers (% price change)

  • ZOLL Medical Corporation (NASDAQ:ZOLL): The shares closed at $37.19, down $3.03, or 7.53%, on the day. Its market capitalization is $823.38 million. About the company: Zoll Medical Corporation designs, manufactures, and markets an integrated line of proprietary, non-invasive resuscitation devices and disposable electrodes. The Company’s products are used by health care professionals to provide pacing and defibrillation. Zoll also designs and markets software that automates collection and management of data for emergency medical service providers.
  • Cleveland BioLabs, Inc. (NASDAQ:CBLI): The shares closed at $3.04, down $0.22, or 6.75%, on the day. Its market capitalization is $107.70 million. About the company: Cleveland Biolabs, Inc. develops pharmaceuticals. The Company develops drugs to protect humans from exposure to radiation.
  • EXACT Sciences Corp. (NASDAQ:EXAS): The shares closed at $7.93, down $0.57, or 6.71%, on the day. Its market capitalization is $417.43 million. About the company: Exact Sciences Corp., is focused on developing and commercializing a non-invasive molecular screening test for the early detection and prevention of colorectal cancer. The Company’s test is a stool-based DNA test that identifies both pre-cancer and cancer by detecting genetic mutations in colorectal cancer cells.
  • Sucampo Pharmaceuticals (NASDAQ:SCMP): The shares closed at $3.34, down $0.24, or 6.7%, on the day. Its market capitalization is $139.89 million. About the company: Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation.
  • Amicus Therapeutics, Inc. (NASDAQ:FOLD): The shares closed at $4.25, down $0.28, or 6.18%, on the day. Its market capitalization is $147.05 million. About the company: Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>